{
  "version": "1.2.0",
  "chapters": [
    {
      "title": "Welcome to Purpose 360",
      "startTime": 0,
      "endTime": 114
    },
    {
      "title": "Introduction to Part 2 with Saundra Pelletier",
      "startTime": 114,
      "endTime": 178.92
    },
    {
      "title": "Evofem's Phexxi",
      "startTime": 178.92,
      "endTime": 330
    },
    {
      "title": "Marketplace Response",
      "startTime": 330,
      "endTime": 398.25
    },
    {
      "title": "Distributing to the Developing World",
      "startTime": 398.25,
      "endTime": 470.75
    },
    {
      "title": "Advice to Women Wanting to Go Into Bioscience",
      "startTime": 470.75,
      "endTime": 605.5
    },
    {
      "title": "Composition of Investors",
      "startTime": 605.5,
      "endTime": 688.5
    },
    {
      "title": "Response From Physicians",
      "startTime": 688.5,
      "endTime": 812
    },
    {
      "title": "Social Media Reactions",
      "startTime": 812,
      "endTime": 920
    },
    {
      "title": "Comparing to the Little Blue Pill",
      "startTime": 920,
      "endTime": 948
    },
    {
      "title": "In the Know",
      "startTime": 948,
      "endTime": 1128
    },
    {
      "title": "Insights for Entrepreneurs Wanting to Advance Women's Sexual Health",
      "startTime": 1128,
      "endTime": 1237
    },
    {
      "title": "Dealing With Cancer",
      "startTime": 1237,
      "endTime": 1434
    },
    {
      "title": "Three Points to Share",
      "startTime": 1434,
      "endTime": 1640
    },
    {
      "title": "Last Thoughts",
      "startTime": 1640,
      "endTime": 1702
    },
    {
      "title": "Wrapping Up",
      "startTime": 1702,
      "endTime": 1857
    }
  ]
}